2025年2月5日， Akero Therapeutics（AKRO）披露2笔公司内部人交易情况。高管Young Jonathan于2025年2月3日卖出5100股。 2025年2月5日 高管 Young Jonathan 2025年2月3日 卖出 4900 54.06 26.49万 2025年2月5日 高管 Young Jonathan 2025年2月3日 卖出 5100 53.57 27.32 ...

Leerink Partners analyst Thomas Smith adjusted the price target for 89bio Inc . (NASDAQ:ETNB) to $37 from $34, while ...

周一，Leerink Partners分析师Thomas Smith将89bio Inc. (NASDAQ: ETNB )的目标价从34美元上调至37美元，同时重申对该股的"优于大市"评级。目前，该股交易价格为9.60美元，远低于分析师12美元至49美元的更广泛目标区间。根据 InvestingPro ...

近来，基于各种新理论和新靶点的MASH新药临床试验结果陆续发布，多项研究已显示部分新药有MASH改善/缓解，肝纤维化改善/逆转等诸多维度的临床获益潜力。2024年11月Journal of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

Akero Therapeutics nearly doubled Monday — and pulled 89bio shares higher — after the company's treatment for MASH ...

After missing the primary endpoint in the Phase IIb SYMMETRY trial, Akero Therapeutics’ lead molecule, efruxifermin, showed ...

Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...

The NOD-like receptor family pyrin domain-containing 3 (NLRP3) is a key pattern recognition receptor in the innate immune system. Its overactivation leads to the production of pro-inflammatory ...

Akero Therapeutics has hit a home run, reporting statistically significant results in two key 96-week metabolic ...

Slingshot is a 2024 American science fiction psychological thriller directed by Mikael Håfström. Released on August 30, 2024, the film features Casey Affleck, Laurence Fishburne, and Emily Beecham.